{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:26:36Z","timestamp":1781933196783,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["517504"],"award-info":[{"award-number":["517504"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011349","name":"University of Texas at El Paso","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12271346"],"award-info":[{"award-number":["12271346"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mathematical Biosciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.mbs.2025.109546","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:12:54Z","timestamp":1759558374000},"page":"109546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Mechanistic embedding of concise physiological absorption models for enhanced prediction in population pharmacokinetic modeling of oral ibuprofen"],"prefix":"10.1016","volume":"390","author":[{"given":"Enwei","family":"Bu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0288-9099","authenticated-orcid":false,"given":"Xiaotian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangning","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mbs.2025.109546_b1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5001\/omj.2010.49","article-title":"An overview of clinical pharmacology of Ibuprofen","volume":"25","author":"Bushra","year":"2010","journal-title":"Oman Med. J."},{"issue":"5","key":"10.1016\/j.mbs.2025.109546_b2","first-page":"2065","article-title":"Possibility of extending biopharmaceutics classification system based biowaiver to BCS class IIa drug","volume":"32","author":"Khalid","year":"2019","journal-title":"Pak. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.mbs.2025.109546_b3","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.817","article-title":"Kidney damage from nonsteroidal anti-inflammatory drugs-Myth or truth? Review of selected literature","volume":"9","author":"Drozdzal","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.mbs.2025.109546_b4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10787-009-0016-x","article-title":"Ibuprofen: pharmacology, efficacy and safety","volume":"17","author":"Rainsford","year":"2009","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.mbs.2025.109546_b5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12325-019-01144-9","article-title":"Ibuprofen safety at the golden anniversary: Are all NSAIDs the same? a narrative review","volume":"37","author":"Varrassi","year":"2020","journal-title":"Adv. Ther."},{"issue":"1A","key":"10.1016\/j.mbs.2025.109546_b6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0002-9343(84)80017-0","article-title":"Pharmacokinetics of ibuprofen","volume":"77","author":"Albert","year":"1984","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.mbs.2025.109546_b7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00007691-200204000-00014","article-title":"Development of population pharmacokinetic models and optimal sampling times for ibuprofen tablet and suspension formulations in children with cystic fibrosis","volume":"24","author":"Beringer","year":"2002","journal-title":"Ther. Drug Monit."},{"issue":"12","key":"10.1016\/j.mbs.2025.109546_b8","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1021\/acs.molpharmaceut.8b00515","article-title":"Linking the gastrointestinal behavior of ibuprofen with the systemic exposure between and within Humans-Part 1: Fasted state conditions","volume":"15","author":"Bermejo","year":"2018","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.mbs.2025.109546_b9","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1111\/bcp.14298","article-title":"Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus","volume":"86","author":"Engbers","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.mbs.2025.109546_b10","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1177\/0091270008323752","article-title":"Population pharmacokinetic analysis of Ibuprofen enantiomers in preterm newborn infants","volume":"48","author":"Gregoire","year":"2008","journal-title":"J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.mbs.2025.109546_b11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s13318-022-00766-9","article-title":"Population pharmacokinetic modelling of acetaminophen and ibuprofen: the influence of body composition, formulation and feeding in healthy adult volunteers","volume":"47","author":"Morse","year":"2022","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.mbs.2025.109546_b12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2165\/00003088-200038060-00004","article-title":"Pharmacokinetic-pharmacodynamic modelling of the antipyretic effect of two oral formulations of ibuprofen","volume":"38","author":"Troc\u00f3niz","year":"2000","journal-title":"Clin. Pharmacokinet."},{"issue":"10","key":"10.1016\/j.mbs.2025.109546_b13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/psp4.12134","article-title":"Applied concepts in PBPK modeling: How to build a PBPK\/PD model","volume":"5","author":"Kuepfer","year":"2016","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"1","key":"10.1016\/j.mbs.2025.109546_b14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/pharmaceutics12010074","article-title":"A mechanistic physiologically-based biopharmaceutics modeling (PBBM) approach to assess the in vivo performance of an orally administered drug product: From IVIVC to IVIVP","volume":"12","author":"Bermejo","year":"2020","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.mbs.2025.109546_b15","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1002\/jps.24076","article-title":"Use of physiologically based pharmacokinetic models coupled with pharmacodynamic models to assess the clinical relevance of current bioequivalence criteria for generic drug products containing Ibuprofen","volume":"103","author":"Cristofoletti","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.mbs.2025.109546_b16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1208\/s12248-020-00495-4","article-title":"Using physiologically based pharmacokinetic modeling to assess the risks of failing bioequivalence criteria: a tale of two ibuprofen products","volume":"22","author":"Loisios-Konstantinidis","year":"2020","journal-title":"AAPS J."},{"key":"10.1016\/j.mbs.2025.109546_b17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106587","article-title":"Comparison of intravenous ibuprofen pharmacokinetics between caucasian and Chinese populations using physiologically based pharmacokinetics modeling and simulation","volume":"191","author":"Jin","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.mbs.2025.109546_b18","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.123.000960","article-title":"Physiologically based pharmacokinetic modeling of small molecules: How much progress have we made?","volume":"53","author":"Isoherranen","year":"2025","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.mbs.2025.109546_b19","series-title":"Ibuprofen oral use (immediate release formulations, 200\u2013800 mg) product-specific bioequivalence guidance \u2013 Revision 1 [Internet]","author":"European Medicines Agency","year":"2023"},{"key":"10.1016\/j.mbs.2025.109546_b20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125015","article-title":"The use of population pharmacokinetics to extrapolate food effects from human adults and beagle dogs to the pediatric population illustrated with ibuprofen as a case","volume":"669","author":"Gasthuys","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.mbs.2025.109546_b21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/10717544.2017.1279238","article-title":"pH-Responsive carriers for oral drug delivery:challenges and opportunities of current platforms","volume":"24","author":"Liu","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.mbs.2025.109546_b22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2024.108720","article-title":"Unravelling pH\/pKa influence on pH-responsive drug carriers: Insights from ibuprofen-silica interactions and comparative analysis with carbon nanotubes, sulfasalazine, and alendronate","volume":"128","author":"Yamin","year":"2024","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.mbs.2025.109546_b23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pain.2013.08.013","article-title":"Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain","volume":"155","author":"Moore","year":"2014","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.mbs.2025.109546_b24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ejp.536","article-title":"Validating speed of onset as a key component of good analgesic response in acute pain","volume":"19","author":"Moore","year":"2015","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.mbs.2025.109546_b25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106788","article-title":"Predicting gastric emptying of drug substances taken under postprandial conditions by combination of biorelevant dissolution and mechanistic in silico modeling","volume":"198","author":"Winter","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.mbs.2025.109546_b26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF01062664","article-title":"Pharmacokinetics of ibuprofen in man IV: absorption and disposition","volume":"12","author":"Wagner","year":"1984","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.mbs.2025.109546_b27","series-title":"Human Bioequivalence Report of Ibuprofen Tablets","year":"2019"},{"issue":"4","key":"10.1016\/j.mbs.2025.109546_b28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11095-022-03230-0","article-title":"Re-writing oral pharmacokinetics using physiologically based finite time pharmacokinetic (PBFTPK) models","volume":"39","author":"Chryssafidis","year":"2022","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.mbs.2025.109546_b29","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1080\/17425255.2021.1951223","article-title":"Crosstalk of physiological pH and chemical pka under the umbrella of physiologically based pharmacokinetic modeling of drug absorption, distribution, metabolism, excretion, and toxicity","volume":"17","author":"Gaohua","year":"2021","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.mbs.2025.109546_b30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114341","article-title":"Drug dissolution and transit in a heterogenous gastric chyme after fed administration: Semi-mechanistic modeling and simulations for an immediate-release and orodispersible tablets containing a poorly soluble drug","volume":"200","author":"Danielak","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.mbs.2025.109546_b31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3390\/ph18030331","article-title":"Intravenous vs. Oral dose comparison of ibuprofen and tramadol combinations\u2014Enantiomers, metabolite, linearity, and Sex-Related Effects: A pharmacokinetics randomized clinical trial","volume":"18","author":"Portol\u00e9s-D\u00edez","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.mbs.2025.109546_b32","article-title":"Pharmacokinetics of obese adults: Not only an increase in weight","volume":"166","author":"Gouju","year":"2023","journal-title":"Biomed Pharmacother. Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.mbs.2025.109546_b33","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2012.4","article-title":"Basic concepts in population modeling, simulation, and model-based drug development","volume":"1","author":"Mould","year":"2012","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.mbs.2025.109546_b34","doi-asserted-by":"crossref","DOI":"10.1016\/j.aml.2022.108242","article-title":"Stochastic HIV model coupled with pharmacokinetics and drug adherence may explain intermittent viral blips","volume":"133","author":"Yan","year":"2022","journal-title":"Appl. Math. Lett."},{"key":"10.1016\/j.mbs.2025.109546_b35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2024.111895","article-title":"Uncertainty quantification for the random HIV dynamical model driven by drug adherence","volume":"592","author":"Yan","year":"2024","journal-title":"J. Theoret. Biol."}],"container-title":["Mathematical Biosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025556425001725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025556425001725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T01:53:09Z","timestamp":1764726789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025556425001725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":35,"alternative-id":["S0025556425001725"],"URL":"https:\/\/doi.org\/10.1016\/j.mbs.2025.109546","relation":{},"ISSN":["0025-5564"],"issn-type":[{"value":"0025-5564","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic embedding of concise physiological absorption models for enhanced prediction in population pharmacokinetic modeling of oral ibuprofen","name":"articletitle","label":"Article Title"},{"value":"Mathematical Biosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mbs.2025.109546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109546"}}